Fig. 1. Currently approved CAR T-cell products and their indications.
Abbreviations: CAR, chimeric antigen receptor; r/r, relapsed or refractory; DLBCL, diffuse large B-cell lymphoma; HGBCL, high-grade B-cell lymphoma; PMBCL, primary mediastinal large B-cell lymphoma; MCL, mantle cell lymphoma; FL, follicular lymphoma; tFL, transformed follicular lymphoma; B-ALL, B-acute lymphoblastic leukemia; MM, multiple myeloma.

Ann Lab Med 2024;44:210~221 https://doi.org/10.3343/alm.2023.0388